cilostazol has been researched along with arginine in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 7 (58.33) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hiatt, WR | 1 |
Ohhashi, T; Yashiro, Y | 1 |
Liu, JH; Ouyang, XL; Wang, DM; Xing, YC; Zhou, J | 1 |
Koizumi, T; Morii, F; Nagakane, Y; Ohara, T; Tanaka, E; Yamamoto, Y | 1 |
Fan, L; Liu, J; Yang, L; Zhang, C; Zhou, J | 1 |
Eno, S; Hondo, T; Iwamoto, A; Kimura, M; Matsuda, K; Matsumura, H | 1 |
Alcantara, R; Baltgalvis, KA; Claypool, MD; Friera, AM; Godinez, G; Goff, D; Gururaja, T; Hansen, D; Hitoshi, Y; Jenkins, Y; Kinsella, TM; Lang, W; Lau, D; Li, W; Li, Y; Markovtsov, V; McCaughey, K; McLaughlin, J; Nguyen, H; Pan, A; Park, G; Payan, DG; Shaw, SJ; Singh, BK; Singh, R; Smith, IJ; Sun, TQ; Uy, G; White, K | 1 |
Yamamoto, Y | 1 |
Choi, MH; Hong, JM; Lee, JS; Lee, SE; Lee, SJ; Shin, DH | 1 |
Abdel-Aziz, AM; Abdel-Gaber, SA; Rifaai, RA | 1 |
4 review(s) available for cilostazol and arginine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New treatment options in intermittent claudication: the US experience.
Topics: Arginine; Carnitine; Cilostazol; Endothelial Growth Factors; Exercise Therapy; Humans; Intermittent Claudication; Multicenter Studies as Topic; Nafronyl; Pentoxifylline; Phosphodiesterase Inhibitors; Prostaglandins; Quality of Life; Randomized Controlled Trials as Topic; Serotonin Antagonists; Tetrazoles; United States | 2001 |
[Concept of branch atheromatous disease (BAD) and its clinical significance].
Topics: Antipyrine; Arginine; Cerebral Infarction; Cilostazol; Drug Therapy, Combination; Edaravone; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Tetrazoles | 2010 |
[Concept, pathophysiology and treatment for branch atheromatous disease].
Topics: Antipyrine; Arginine; Cerebral Infarction; Cilostazol; Clopidogrel; Contraindications; Drug Therapy, Combination; Edaravone; Humans; Magnetic Resonance Imaging; Pipecolic Acids; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Sulfonamides; Tetrazoles; Ticlopidine; Tissue Plasminogen Activator | 2014 |
1 trial(s) available for cilostazol and arginine
Article | Year |
---|---|
Cilostazol improves endothelial function in acute cerebral ischemia patients: a double-blind placebo controlled trial with flow-mediated dilation technique.
Topics: Adult; Aged; Arginine; Aspirin; Brain Ischemia; C-Reactive Protein; Cilostazol; Dilatation; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Prospective Studies; Tetrazoles | 2017 |
7 other study(ies) available for cilostazol and arginine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Age-dependent changes in the regulatory roles of nitric oxide and vasodilator prostanoids on the mechanical activities of isolated rabbit spinal arterioles.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Age Factors; Aging; Animals; Arginine; Arterioles; Cilostazol; Dose-Response Relationship, Drug; Epoprostenol; Female; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Prostaglandins; Rabbits; Spinal Cord; Tetrazoles; Vasodilation; Vasodilator Agents | 2003 |
[Inhibition of L-arginine and cilostazol on activation of platelets in vitro].
Topics: Arginine; Blood Platelets; Cilostazol; Humans; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles | 2007 |
Loading solution prevents activation damage of human platelets before lyophilization.
Topics: Adenosine; Algorithms; Alprostadil; Arginine; Biomarkers; Blood Platelets; Blood Preservation; Cell Size; Cilostazol; Excipients; Freeze Drying; Hirudins; Humans; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Membrane Glycoproteins; Recombinant Proteins; Tetrazoles | 2011 |
A case of acute coronary artery occlusion associated with very rapid onset heparin-induced thrombosis without thrombocytopenia.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Aspirin; Autoantibodies; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Drug Therapy, Combination; Female; Heart Failure; Heparin; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Stents; Sulfonamides; Tetrazoles; Thrombosis; Ticlopidine; Time Factors | 2012 |
Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Arginine; Cilostazol; Diet, High-Fat; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Humans; Intermittent Claudication; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Fatigue; Muscle, Skeletal; Nitric Oxide Synthase Type III; Obesity; Peripheral Vascular Diseases; Phosphodiesterase 3 Inhibitors; Physical Exertion; Tetrazoles; Vasodilator Agents | 2014 |
Possible mechanisms mediating the protective effect of cilostazol in L-arginine induced acute pancreatitis in rats: role of cGMP, cAMP, and HO-1.
Topics: Animals; Arginine; Cilostazol; Cyclic AMP; Cyclic GMP; Heme Oxygenase (Decyclizing); Male; Oxidative Stress; Pancreatitis; Phosphodiesterase 3 Inhibitors; Rats; Rats, Wistar | 2020 |